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Sneddon's syndrotne with anticardiolipin antibodies
complications and treattnent
B. P. LOTZ, C.-M. SCHUTTE, P. F. COLIN, L. D. BIERMANN
Abstract We investigated 2 patients with Sneddon's syn-
drome, elevated anticardiolipin antibodies and
systemic complications, which included stroke,
habitual abortions, cardiac valvular lesions, acro-
cyanosis, hypertension and renal insufficiency.
TreatInent with a combination of hnmunosup-
pressive agents and warfarin or aspirin prevented
further complications and hnproved renal func-
tion. It is hnportant for those in different special-
ties to be aware of this potentially treatable disor-
der.
S AIr Med J 1993; 83: 663-664.
I n 1965, Sneddon
I described 6 patients with a com-
bination of severe livedo reticularis (LR), cerebrovas-
cular incidents and mild hypenension. He postu-
lated that the underlying pathology in such patients is
endaneritis obliterans, even though most skin biopsies
are normal or show nonspecific changes.'" An associa-
tion between antiphospholipid antibodies (APAs) and
LR was reponed in 1984 by Hughes' in patients with
systemic lupus erythematosus, and by Jonas et al.' in
.1986 in patients with Sneddon's syndrome. Subsequent
reports established an association, panicularly for anti-
cardiolipin antibodies (ACAs) and Sneddon's syn-
drome. It also became apparent that these patients
might develop other complications, including habitual
abonions, anerial and venous thrombosis, haemolytic
anaemia and disturbed peripheral circulation. 6. 8
Treatment of this condition remains controversial and
antiplatelet agents, anticoagulants, immunosuppression,
splenectomy and plasmapheresis have all been used,
with variable results"'1O
We repon on 2 patients with positive serum ACAs




A 34-year-old white woman, who had suffered a left-
sided stroke 5 years earlier, presented in January 1989.
She had a history of 8 pregnancies of which 7 had spon-
taneously aboned. The 5th pregnancy had lasted until
the 28th week and she had given binh to a healthy pre-
mature infant. Clinical examination confirmed the left-
sided hemiparesis. She had marked generalised race-
mose LR and acrocyanosis; a clinical diagnosis of
Sneddon's syndrome was made. Laboratory investiga-
tions revealed the following abnormalities: serum creati-
nine level 124,6 fJIIlol/l (normal range 67 - 97 iJIIlo]Jrnl),
total complement 134 micro. complement haemolysed
Department ofNeurology, University ofPretoria
B. P. LOTZ, M.B. CH.B., F.C.P. (l'-.'EUR.), M.MED. (l'-.'EUR.)
C.-M. SCHUTTE, M.B. CH.B
P. F. COLIN, M.B. CH.B.,M.MED. PSYCH.
L. D. BIERMANN, M.B. CH.B., M.MED. (l'-.'EUR.), F.C.P. (l'-.'EUR.)
Accepted 10 Jun 1992.
UIiits per millilitre serum (IlCH U/ml) (normal range
150 - 200 IlCH U/rnl) with normal C3 and C4 values, a
panial thromboplastin time (PTT) of 35,4 seconds
(normal range 24 - 36 seconds), and positive reagen
flocculation and Treponema pallidum haemagglutination
(TPHA) test results. The fluorescent treponemal anti-
body absorption test (FTA-ABS) was positive for
immunoglobulin G (IgG), but not for IgM. A skin biop-
sy from a livedoid area on the arm was normal. Com-
puted tomography (CT) of the brain showed infarcts in
the distribution of born middle cerebral aneries. The
patient was treated with aspirin 300 mg daily and
became pregnant 5 months later. Prednisone 60 mg/d
was given in addition to the aspirin,IO but unfonunately
she aborted at 10 weeks' gestation. Prednisone was
tapered and stopped, but after 10 days without pred-
nisone she suffered an acute exacerbation of her previ-
ous left-sided stroke. Laboratory investigations pro-
duced results similar to those at first admission with me
following exceptions: negative serological tests for
syphilis (STS) and positive ACAs wim a titre of 1:68
(normal range 1:40). She was negative for lupus anti-
coagulant (LA) as assayed by means of the dilute tissue
thromboplastin test." Ei:hocardiography revealed slight
mitral incompetence without valvular vegetations or
chamber dilatations. CT of the brain showed infarcts in
the right anterior cerebral and the right and left middle
cerebral anery distributions (Fig. 1).
FIG. 1
Computed tomographic scan of the brain shOWing
infarcts in the right anterior cerebral and right and left
middle cerebral artery distributions.
The acrocyanosis responded well to nifedipine 10 mg
twice daily and captopril 12,5 mg twice daily. Immer-
sion of the hands for 10 minutes in warm water alle-
viated the cyanosis, but left bright red markings where
the livedo changes had taken place. Treatment was
started with warfarin and azathioprine 50 mg twice
daily. Follow-up over 3 years showed no funher exacer-
bations of her disease and serum creatinine levels nor-
malised, but she remained cognitively impaired.
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ease 2
A 33-year.-old white woman presented with a history of
hYpertensIOn, classic migraine for 4 years, temporal lobe
epilepsy WIth onset 3 years previously and ataxia, with a
tendency to fall to the right. Since 1983 she had had 5
spontaneous abortions durin a the first or second
trimesters of pregnancy. She had 1 child born at term
in 1980. She smoked an average of 20 cig~rettes per day
anp. was taking carbamazepine and captopril.
Examination revealed a blood pressure of 170/100
mmHg, acrocyanosis of the hands and feet which abated
on immersion in warm water, and severe generalised
racemose LR. The findings on neurological examination
were normal, as was a full blood count, the erythrocyte
sedlm~ntatlon rate, levels of auro-antibody, immuno-
glo.bulm and .total complement, and the cerebrospinal
flUId. SerologIcal testing for syphilis was negative. The
serum urea level was 7,4 mmol/l (normal range < 6,4
~ol/l) .and creanrune clearance 72 ml/min; prothrom-
bm actlVlty and partial thromboplastin time were normal
on two occasions. She was negative for LA and ACA-
positive in a titre of 1:62. Heart echocardiographic
assessment showed mild mitral and tricuspid valve
mcom.petence, electro-encephalography revealed a right
postenor temporal lobe epileptiform dysfunction and
magnetic resonance imaging of the brain showed three
small ~arcts: 1 occipital, 1 in the right temporal lobe
and 1 m the left cerebellutn.
.The patient w~s treated with azathioprine 50 mg
~ce. a. day, prednisone 15 mg/d, aspirin 325 mg/d and
, nifedIpme 10 mg 3 times a day. Follow-up at 6 months
showed no evidence of further strokes. Serum urea and
creatinine valves normalised, but she still had hyperten-
sion and moderate acrocyanosis.
Discussion
The LA and ACA are the two best characterised groups
of serum immunoglobulins (IgG or IgM) that bind
phospholipid moieties. Asphospholipids are a major
constltuent of cellular membranes and coagulation fac-
tors, binding may alter cellular structure and function. 12
This is postulated to be the basis for the numerous com-
plications and abnormal blood coagulation observed in
these disorders. 6-8 However, the exact importance of
these antibodies in the pathogenesis of the disorders is
still unclear, as these antibodies are also present in up to
11 % of normal pregnant womenl3 and are nor present in
all patients with Sneddon's syndrome.
The_ 2 patients wi·th ACAs and Sneddon's syn-
dro~e6,' had· th~ following complications: stroke, LR,
habitual abortlons, acrocyanosis, cardiac valvular
lesions, renal insufficiency, migraine and epilepsy sec-
ondary to a temporal lobe stroke. Similar complications
have bee~ reported in the neurology literature:" but
have received little auention in general medical journals.
Treatltlent of patients with APA withour an asso-
ciated auto-immune disorder remains controversialY'
Patients treated with oral anticoagulation and anti-
platelet agents have had variable clinical responses. An
apparent association between ACA titres and thrombo-
tic symptoms h~s prompted the use of immunosuppres-
sive treatltlent. l , Asherson et a!. 16 reponed on 6 patients
who had ACA-associated thrombotic events after cessa-
tion of warfarin therapy even though they were still
receiving prednisone and azathioprine at the time. All
had raised ACA levels at the time of recurrence; this
supports the theory of an association between raised
APA levels and thrombotic tendencies. There was a
close temporal relationship between the withdrawal of
prednisone therapy and recurrence of stroke in patient 1.
ThiS suggests that cessation of immunosuppressive
therapy C;an result in a rebound increase in thrombotic
complications, which is nor prevented by the simultane-
ous use of antiplatelet agents. It therefore seems appro-
pnate to monitor ACA titres and LA activity, especially
postpartum or postabortum, before immunosuppressive
or anocoagulant therapy is reduced. Our patients had
no further recurrences of thrombotic complications and
both showed improvement of renal function on a com-
bination of azathioprine and warfarin or azathioprine
and low-dose prednisone and aspirin.
Lubbe et a!. 10 used prednisone to suppress maternal
LA in 6 pregnant patients, 5 of whom gave- birth to live
infants. UnfortUnately, prednisone treatltlent did not
p~event abortion in patient 1. It is not clear if pred-
nIsone therapy IS more beneficial in patients with LA
than in those with ACAs. Campbell et al./ 7 ho'wever,
used a combination of warfarin and prednisone success-
fully in a pregnant patient with ACAs.
In patient 1, initially positive serological tests for
syphilis became negative after prednisone therapy. The
specific treponemal antibody tests (FTA and TPHA)
can be false-positive in the presence of APA and since
prednisone therapy would not normalise a true positive
test for syphilis, this confirmed the initial false-positivity
of these tests. Surprisingly, previous workers did not
address this potentially confusing issue, for strokes
habitual abortions, LR and even ACAs can all occur a~
complications in syphilis.
In both patients severe acrocyanosis threatened the
viability. ~f fingers and toes. The response to warming of
extremities m water and to treannent with calcium
~hannel blockers indicated that this was at least partially
mduced by vasospas!? As steroid therapy might aggra-
vate vas?s~;~m? parncularly in patients with underlying
vasculms, It IS Important to treat the acrocyanosis
sYJ?ptomatically, in addition to the therapy aimed at the
pnmary dIsease.
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